164 related articles for article (PubMed ID: 5720808)
1. Continuously propagated cell lines. Biochemical identification standards--discussion.
Peterson WD
Natl Cancer Inst Monogr; 1968 Dec; 29():55-7. PubMed ID: 5720808
[No Abstract] [Full Text] [Related]
2. Continuously propagated cell lines. Identification standards: serology.
Brand KG
Natl Cancer Inst Monogr; 1968 Dec; 29():51-3. PubMed ID: 5720805
[No Abstract] [Full Text] [Related]
3. Identification standards of primary cultures and diploid cell lines--discussion.
Stulberg CS
Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
[No Abstract] [Full Text] [Related]
4. Vaccines produced in diploid cell lines--discussion.
Perkins FT
Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
[No Abstract] [Full Text] [Related]
5. Large-scale production of indefinitely propagated cell lines.
Cooper PD
Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812
[No Abstract] [Full Text] [Related]
6. Cells, vaccines, and the pursuit of precedent.
Hilleman MR
Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933
[No Abstract] [Full Text] [Related]
7. Comments on technology of production--continuous cell lines.
Daniels WF
Natl Cancer Inst Monogr; 1968 Dec; 29():71-2. PubMed ID: 5720813
[No Abstract] [Full Text] [Related]
8. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
9. Identification of established cell lines with reference to karyology.
Moorhead PS
Natl Cancer Inst Monogr; 1968 Dec; 29():45-50. PubMed ID: 4305438
[No Abstract] [Full Text] [Related]
10. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
11. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
Dawe CJ
Natl Cancer Inst Monogr; 1968 Dec; 29():229-32. PubMed ID: 5720795
[No Abstract] [Full Text] [Related]
12. Tissue and medium antigens in vaccines.
Coriell LL
Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
[No Abstract] [Full Text] [Related]
13. Technology of production of primary and diploid cell cultures.
Brackett RG
Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
[No Abstract] [Full Text] [Related]
14. Cell substrates for human virus vaccine preparation--general comments.
Hayflick L
Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814
[No Abstract] [Full Text] [Related]
15. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
16. Experience with an established cell line for veterinary vaccine production.
Brown AL
Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440
[No Abstract] [Full Text] [Related]
17. Neoplastic properties of animal cell lines--general comments.
Macpherson I
Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360
[No Abstract] [Full Text] [Related]
18. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
19. Viral flora of primate tissues--discussion.
Malherbe H
Natl Cancer Inst Monogr; 1968 Dec; 29():177-8. PubMed ID: 5720790
[No Abstract] [Full Text] [Related]
20. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties.
Foley GE
Natl Cancer Inst Monogr; 1968 Dec; 29():217-28. PubMed ID: 4888929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
